Gastrointestinal involvement in systemic sclerosis: An update

Research output: Contribution to journalReview article

Abstract

Purpose of reviewThis review provides important updates in systemic sclerosis (SSc)-related gastrointestinal disease, specifically focusing on the most recent literature.Recent findingsIn the past year, several studies were published that present interesting insights into SSc and gastrointestinal disease. Studies focusing on newly identified risk factors, novel approaches to diagnosis and assessment of disease activity, survival and quality of life demonstrate progress in our understanding of this challenging area. Additional data on specific SSc gastrointestinal-related topics, such as the link between gastrointestinal and pulmonary disease, nutrition, and the microbiome, are also now available.SummarySSc gastrointestinal disease is heterogeneous in its clinical presentation, which presents a challenge in diagnosis and management. In the past year, several studies have evaluated risk factors and clinical features associated with specific gastrointestinal complications in SSc. Objective gastrointestinal testing may help to identify specific SSc gastrointestinal subgroups and provide diagnostic accuracy to guide targeted therapies. Survival in very early SSc is affected by the severity of gastrointestinal involvement. Other important gastrointestinal subsets, including patients with esophageal disease and interstitial lung disease, should carefully be considered when developing a management plan for this patient population.

Original languageEnglish (US)
Pages (from-to)561-568
Number of pages8
JournalCurrent opinion in rheumatology
Volume31
Issue number6
DOIs
StatePublished - Nov 1 2019

Fingerprint

Systemic Scleroderma
Gastrointestinal Diseases
Esophageal Diseases
Survival
Microbiota
Interstitial Lung Diseases
Lung Diseases
Quality of Life
Population

Keywords

  • diagnosis
  • dysmotility
  • gastrointestinal
  • management
  • systemic sclerosis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Gastrointestinal involvement in systemic sclerosis : An update. / McMahan, Zsuzsanna.

In: Current opinion in rheumatology, Vol. 31, No. 6, 01.11.2019, p. 561-568.

Research output: Contribution to journalReview article

@article{7d03bd91e75d4838bdf454d41a2ca2ec,
title = "Gastrointestinal involvement in systemic sclerosis: An update",
abstract = "Purpose of reviewThis review provides important updates in systemic sclerosis (SSc)-related gastrointestinal disease, specifically focusing on the most recent literature.Recent findingsIn the past year, several studies were published that present interesting insights into SSc and gastrointestinal disease. Studies focusing on newly identified risk factors, novel approaches to diagnosis and assessment of disease activity, survival and quality of life demonstrate progress in our understanding of this challenging area. Additional data on specific SSc gastrointestinal-related topics, such as the link between gastrointestinal and pulmonary disease, nutrition, and the microbiome, are also now available.SummarySSc gastrointestinal disease is heterogeneous in its clinical presentation, which presents a challenge in diagnosis and management. In the past year, several studies have evaluated risk factors and clinical features associated with specific gastrointestinal complications in SSc. Objective gastrointestinal testing may help to identify specific SSc gastrointestinal subgroups and provide diagnostic accuracy to guide targeted therapies. Survival in very early SSc is affected by the severity of gastrointestinal involvement. Other important gastrointestinal subsets, including patients with esophageal disease and interstitial lung disease, should carefully be considered when developing a management plan for this patient population.",
keywords = "diagnosis, dysmotility, gastrointestinal, management, systemic sclerosis",
author = "Zsuzsanna McMahan",
year = "2019",
month = "11",
day = "1",
doi = "10.1097/BOR.0000000000000645",
language = "English (US)",
volume = "31",
pages = "561--568",
journal = "Current Opinion in Rheumatology",
issn = "1040-8711",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Gastrointestinal involvement in systemic sclerosis

T2 - An update

AU - McMahan, Zsuzsanna

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Purpose of reviewThis review provides important updates in systemic sclerosis (SSc)-related gastrointestinal disease, specifically focusing on the most recent literature.Recent findingsIn the past year, several studies were published that present interesting insights into SSc and gastrointestinal disease. Studies focusing on newly identified risk factors, novel approaches to diagnosis and assessment of disease activity, survival and quality of life demonstrate progress in our understanding of this challenging area. Additional data on specific SSc gastrointestinal-related topics, such as the link between gastrointestinal and pulmonary disease, nutrition, and the microbiome, are also now available.SummarySSc gastrointestinal disease is heterogeneous in its clinical presentation, which presents a challenge in diagnosis and management. In the past year, several studies have evaluated risk factors and clinical features associated with specific gastrointestinal complications in SSc. Objective gastrointestinal testing may help to identify specific SSc gastrointestinal subgroups and provide diagnostic accuracy to guide targeted therapies. Survival in very early SSc is affected by the severity of gastrointestinal involvement. Other important gastrointestinal subsets, including patients with esophageal disease and interstitial lung disease, should carefully be considered when developing a management plan for this patient population.

AB - Purpose of reviewThis review provides important updates in systemic sclerosis (SSc)-related gastrointestinal disease, specifically focusing on the most recent literature.Recent findingsIn the past year, several studies were published that present interesting insights into SSc and gastrointestinal disease. Studies focusing on newly identified risk factors, novel approaches to diagnosis and assessment of disease activity, survival and quality of life demonstrate progress in our understanding of this challenging area. Additional data on specific SSc gastrointestinal-related topics, such as the link between gastrointestinal and pulmonary disease, nutrition, and the microbiome, are also now available.SummarySSc gastrointestinal disease is heterogeneous in its clinical presentation, which presents a challenge in diagnosis and management. In the past year, several studies have evaluated risk factors and clinical features associated with specific gastrointestinal complications in SSc. Objective gastrointestinal testing may help to identify specific SSc gastrointestinal subgroups and provide diagnostic accuracy to guide targeted therapies. Survival in very early SSc is affected by the severity of gastrointestinal involvement. Other important gastrointestinal subsets, including patients with esophageal disease and interstitial lung disease, should carefully be considered when developing a management plan for this patient population.

KW - diagnosis

KW - dysmotility

KW - gastrointestinal

KW - management

KW - systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=85072791643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072791643&partnerID=8YFLogxK

U2 - 10.1097/BOR.0000000000000645

DO - 10.1097/BOR.0000000000000645

M3 - Review article

C2 - 31389815

AN - SCOPUS:85072791643

VL - 31

SP - 561

EP - 568

JO - Current Opinion in Rheumatology

JF - Current Opinion in Rheumatology

SN - 1040-8711

IS - 6

ER -